Xenon Pharmaceuticals (XENE) Schedules Webcast for October 4th, 7AM EST to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101

Go back to Xenon Pharmaceuticals (XENE) Schedules Webcast for October 4th, 7AM EST to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
(NASDAQ: XENE) Delayed: 59.75 --0 (-0%)
Previous Close $59.75    52 Week High $9.75 
Open $59.75    52 Week Low $5.65 
Day High $59.75    P/E N/A 
Day Low $59.75    EPS $0.00 
Volume 1,037